Unichem Labs' Q2 FY25 financials show strong growth in key areas.

Unichem Laboratories, a midcap pharmaceutical company, has recently declared its financial results for the quarter Q2 FY24-25. The company has shown a very positive performance, with its score rising from 29 to 27 in the last 3 months.

According to the Sep 2024 financials, Unichem Labs has seen significant growth in key areas. The Profit Before Tax (PBT) less Other Income has grown by 637.8% to Rs 24.20 crore, compared to the average PBT of the previous four quarters which was Rs -4.50 crore. This shows a very positive trend in the near term for PBT.

Similarly, the Profit After Tax (PAT) has also shown a remarkable growth of 4248.3% to Rs 30.49 crore, compared to the average PAT of the previous four quarters which was Rs -0.74 crore. This is a clear indication of the company’s strong financial performance in the near term.

Unichem Labs has also shown a consistent growth in its Operating Cash Flow, with the highest amount of Rs 16.69 crore in the last three years. This shows that the company has been able to generate higher cash revenues from its business operations.

The company’s ability to manage interest payments has also improved, with the Operating Profit to Interest ratio being the highest at 12.01 times in the last five quarters. This is a positive sign for investors.

In terms of sales, Unichem Labs has shown a positive trend with the highest Net Sales of Rs 462.16 crore in the last five quarters. This indicates a strong demand for the company’s products in the market.

The Operating Profit (PBDIT) has also shown a positive trend, with the highest amount of Rs 57.53 crore in the last five quarters. This shows that the company’s operating efficiency has improved.

Unichem Labs has also shown a positive trend in its Operating Profit Margin, with the highest margin of 12.45% in the last five quarters. This indicates that the company has become more efficient in managing its costs.

Overall, Unichem Laboratories has shown a very positive financial performance in the recent quarter, with its key indicators showing significant growth. This makes it a promising stock for investors, with MarketsMOJO giving it a ‘Buy’ call.